{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T02:52:22Z","timestamp":1780368742271,"version":"3.54.1"},"reference-count":63,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T00:00:00Z","timestamp":1758585600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010877","name":"ViiV Healthcare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010877","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004330","name":"GSK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajkd.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Kidney Diseases"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1053\/j.ajkd.2025.06.022","type":"journal-article","created":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T21:46:09Z","timestamp":1758577569000},"page":"843-853","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Pharmaceutical Practice Considerations Regarding Adoption of the Race-Free Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) 2021 Equations"],"prefix":"10.1053","volume":"86","author":[{"given":"Ruth","family":"Tarzi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"McKenzie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Reid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophia","family":"Goodison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Oyee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas F.","family":"Hiemstra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maciej J.","family":"Zamek-Gliszczynski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Muoneke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie A.","family":"Obert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nneka","family":"Nwokolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Richards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1053\/j.ajkd.2025.06.022_bib1","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1053\/j.ajkd.2021.04.016","article-title":"Measurement and estimation of GFR for use in clinical practice: core curriculum 2021","volume":"78","author":"Inker","year":"2021","journal-title":"Am J Kidney Dis"},{"issue":"9","key":"10.1053\/j.ajkd.2025.06.022_bib2","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"issue":"12","key":"10.1053\/j.ajkd.2025.06.022_bib3","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2203033119","article-title":"Genetic ancestry in precision medicine is reshaping the race debate","volume":"119","author":"Krainc","year":"2022","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"10.1053\/j.ajkd.2025.06.022_bib4","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/s41581-021-00501-8","article-title":"Health inequities and the inappropriate use of race in nephrology","volume":"18","author":"Eneanya","year":"2022","journal-title":"Nat Rev Nephrol"},{"issue":"7","key":"10.1053\/j.ajkd.2025.06.022_bib5","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.2215\/CJN.01780221","article-title":"Racial health inequities and clinical algorithms: a time for action","volume":"16","author":"Neal","year":"2021","journal-title":"Clin J Am Soc Nephrol"},{"issue":"5","key":"10.1053\/j.ajkd.2025.06.022_bib6","doi-asserted-by":"crossref","first-page":"806","DOI":"10.2215\/CJN.12640820","article-title":"The pathogenesis of race and ethnic disparities: targets for achieving health equity","volume":"16","author":"Powe","year":"2021","journal-title":"Clin J Am Soc Nephrol"},{"issue":"9","key":"10.1053\/j.ajkd.2025.06.022_bib7","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1056\/NEJMms2004740","article-title":"Hidden in plain sight - reconsidering the use of race correction in clinical algorithms","volume":"383","author":"Vyas","year":"2020","journal-title":"N Engl J Med"},{"issue":"19","key":"10.1053\/j.ajkd.2025.06.022_bib8","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1056\/NEJMoa2102953","article-title":"New creatinine- and cystatin C-based equations to estimate GFR without race","volume":"385","author":"Inker","year":"2021","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1053\/j.ajkd.2025.06.022_bib9","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1053\/j.ajkd.2021.03.008","article-title":"Reassessing the inclusion of race in diagnosing kidney diseases: an interim report from the NKF-ASN Task Force","volume":"78","author":"Delgado","year":"2021","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"10.1053\/j.ajkd.2025.06.022_bib10","doi-asserted-by":"crossref","first-page":"213","DOI":"10.18865\/ed.26.2.213","article-title":"Racial disparities in creatinine-based kidney function estimates among HIV-infected adults","volume":"26","author":"Anker","year":"2016","journal-title":"Ethn Dis"},{"issue":"4","key":"10.1053\/j.ajkd.2025.06.022_bib11","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1093\/clinchem\/hvab279","article-title":"Limited evidence for use of a black race modifier in eGFR calculations: a systematic review","volume":"68","author":"Marzinke","year":"2022","journal-title":"Clin Chem"},{"issue":"8","key":"10.1053\/j.ajkd.2025.06.022_bib12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0255869","article-title":"Estimated glomerular filtration rate equations in people of self-reported black ethnicity in the United Kingdom: inappropriate adjustment for ethnicity may lead to reduced access to care","volume":"16","author":"Gama","year":"2021","journal-title":"PLoS One"},{"issue":"2","key":"10.1053\/j.ajkd.2025.06.022_bib13","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1053\/j.ajkd.2021.08.003","article-title":"A unifying approach for GFR estimation: recommendations of the NKF-ASN Task Force on reassessing the inclusion of race in diagnosing kidney disease","volume":"79","author":"Delgado","year":"2022","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"10.1053\/j.ajkd.2025.06.022_bib14","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1053\/j.ajkd.2021.10.001","article-title":"Removing race from kidney disease diagnosis","volume":"79","author":"Quaggin","year":"2022","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"10.1053\/j.ajkd.2025.06.022_bib15","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1093\/jalm\/jfad022","article-title":"AACC\/NKF guidance document on improving equity in chronic kidney disease care","volume":"8","author":"Pierre","year":"2023","journal-title":"J Appl Lab Med"},{"issue":"4S","key":"10.1053\/j.ajkd.2025.06.022_bib16","first-page":"S117","article-title":"KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease","volume":"105","year":"2024","journal-title":"Kidney Int"},{"issue":"23","key":"10.1053\/j.ajkd.2025.06.022_bib17","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1001\/jama.2022.8801","article-title":"Association of estimated GFR calculated using race-free equations with kidney failure and mortality by Black vs non-Black race","volume":"327","author":"Guti\u00e9rrez","year":"2022","journal-title":"JAMA"},{"issue":"2","key":"10.1053\/j.ajkd.2025.06.022_bib20","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1053\/j.ajkd.2023.05.012","article-title":"Impact of using the race-free 2021 CKD-EPI creatinine equation on treatment effects on GFR-based end points in clinical trials","volume":"83","author":"Chaudhari","year":"2024","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"10.1053\/j.ajkd.2025.06.022_bib21","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1097\/MNH.0000000000000739","article-title":"The \u201crace\u201d correction in estimating glomerular filtration rate: an European point of view","volume":"30","author":"Delanaye","year":"2021","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"5","key":"10.1053\/j.ajkd.2025.06.022_bib22","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/j.kint.2022.02.022","article-title":"Americentrism in estimation of glomerular filtration rate equations","volume":"101","author":"Delanaye","year":"2022","journal-title":"Kidney Int"},{"issue":"8","key":"10.1053\/j.ajkd.2025.06.022_bib23","doi-asserted-by":"crossref","first-page":"e1080","DOI":"10.1016\/S2214-109X(22)00279-0","article-title":"Measuring kidney function: the voice of Africa","volume":"10","author":"Niang","year":"2022","journal-title":"Lancet Glob Health"},{"issue":"1","key":"10.1053\/j.ajkd.2025.06.022_bib24","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1093\/ndt\/gfac241","article-title":"Performance of creatinine-based equations to estimate glomerular filtration rate in White and Black populations in Europe, Brazil and Africa","volume":"38","author":"Delanaye","year":"2023","journal-title":"Nephrol Dial Transplant"},{"issue":"8","key":"10.1053\/j.ajkd.2025.06.022_bib25","doi-asserted-by":"crossref","first-page":"e1159","DOI":"10.1016\/S2214-109X(22)00239-X","article-title":"Measurement of kidney function in Malawi, South Africa, and Uganda: a multicentre cohort study","volume":"10","author":"Fabian","year":"2022","journal-title":"Lancet Glob Health"},{"issue":"4","key":"10.1053\/j.ajkd.2025.06.022_bib26","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1093\/ndt\/gfad219","article-title":"Accuracy of GFR estimating equations based on creatinine, cystatin C or both in routine care","volume":"39","author":"Fu","year":"2024","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"10.1053\/j.ajkd.2025.06.022_bib27","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/ndt\/gfac197","article-title":"Removing race from the CKD-EPI equation and its impact on prognosis in a predominantly White European population","volume":"38","author":"Fu","year":"2023","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"10.1053\/j.ajkd.2025.06.022_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/ndt\/gfac254","article-title":"What should European nephrology do with the new CKD-EPI equation?","volume":"38","author":"Gansevoort","year":"2023","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/j.ajkd.2025.06.022_bib29","article-title":"Impact of Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) GFR estimating equations on CKD prevalence and classification among Asians","volume":"9","author":"Betzler","year":"2022","journal-title":"Front Med (Lausanne)"},{"issue":"7","key":"10.1053\/j.ajkd.2025.06.022_bib30","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1093\/ndt\/gfad241","article-title":"Diagnostic standard: assessing glomerular filtration rate","volume":"39","author":"Delanaye","year":"2024","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"10.1053\/j.ajkd.2025.06.022_bib31","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1093\/jalm\/jfae002","article-title":"The new creatinine-based Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) 2021 equation: potential impact on screening for chronic kidney disease in an asymptomatic Black African population","volume":"9","author":"Omuse","year":"2024","journal-title":"J Appl Lab Med"},{"issue":"4","key":"10.1053\/j.ajkd.2025.06.022_bib32","doi-asserted-by":"crossref","first-page":"247","DOI":"10.7326\/0003-4819-145-4-200608150-00004","article-title":"Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate","volume":"145","author":"Levey","year":"2006","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1053\/j.ajkd.2025.06.022_bib34","doi-asserted-by":"crossref","first-page":"183","DOI":"10.7326\/M20-4366","article-title":"Development and validation of a modified full age spectrum creatinine-based equation to estimate glomerular filtration rate: a cross-sectional analysis of pooled data","volume":"174","author":"Pottel","year":"2021","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1053\/j.ajkd.2025.06.022_bib35","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.kint.2023.11.024","article-title":"Performance of the European Kidney Function Consortium (EKFC) creatinine-based equation in United States cohorts","volume":"105","author":"Delanaye","year":"2024","journal-title":"Kidney Int"},{"issue":"6","key":"10.1053\/j.ajkd.2025.06.022_bib36","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1159\/000536243","article-title":"Glomerular filtration rate estimation in adults: myths and promises","volume":"148","author":"Delanaye","year":"2024","journal-title":"Nephron"},{"issue":"10","key":"10.1053\/j.ajkd.2025.06.022_bib37","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1681\/ASN.2007020199","article-title":"Evaluation of the modification of diet in renal disease study equation in a large diverse population","volume":"18","author":"Stevens","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.ajkd.2025.06.022_bib38","article-title":"The glomerular filtration rate: from the diagnosis of kidney function to a public health tool","volume":"8","author":"Cusumano","year":"2021","journal-title":"Front Med (Lausanne)"},{"issue":"9","key":"10.1053\/j.ajkd.2025.06.022_bib39","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1007\/s11255-016-1357-1","article-title":"Comparisons of GFR estimation using the CKD Epidemiology Collaboration (CKD-EPI) equation and other creatinine-based equations in Asian population: a systematic review","volume":"48","author":"Sudchada","year":"2016","journal-title":"Int Urol Nephrol"},{"issue":"1","key":"10.1053\/j.ajkd.2025.06.022_bib40","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1053\/j.ackd.2017.10.005","article-title":"Glomerular filtration rates in Asians","volume":"25","author":"Teo","year":"2018","journal-title":"Adv Chronic Kidney Dis"},{"issue":"5","key":"10.1053\/j.ajkd.2025.06.022_bib41","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12051822","article-title":"Optimal glomerular filtration rate equations for various age groups, disease conditions and ethnicities in Asia: a systematic review","volume":"12","author":"Safdar","year":"2023","journal-title":"J Clin Med"},{"issue":"1","key":"10.1053\/j.ajkd.2025.06.022_bib42","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1053\/j.ajkd.2021.03.009","article-title":"Race and the estimation of GFR: getting it right","volume":"78","author":"Feldman","year":"2021","journal-title":"Am J Kidney Dis"},{"issue":"12","key":"10.1053\/j.ajkd.2025.06.022_bib43","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1681\/ASN.0000000000000227","article-title":"CKD-EPI and EKFC GFR estimating equations: performance and other considerations for selecting equations for implementation in adults","volume":"34","author":"Inker","year":"2023","journal-title":"J Am Soc Nephrol"},{"issue":"10","key":"10.1053\/j.ajkd.2025.06.022_bib44","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.34067\/KID.0003202022","article-title":"Advantages, limitations, and clinical considerations in using cystatin C to estimate GFR","volume":"3","author":"Chen","year":"2022","journal-title":"Kidney360"},{"issue":"12","key":"10.1053\/j.ajkd.2025.06.022_bib45","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0243618","article-title":"Clinician perspectives on inpatient cystatin C utilization: a qualitative case study at Mayo Clinic","volume":"15","author":"Markos","year":"2020","journal-title":"PLoS One"},{"issue":"10","key":"10.1053\/j.ajkd.2025.06.022_bib46","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0276252","article-title":"Systematic review of international studies evaluating MDRD and CKD-EPI estimated glomerular filtration rate (eGFR) equations in Black adults","volume":"17","author":"Umeukeje","year":"2022","journal-title":"PLoS One"},{"issue":"4","key":"10.1053\/j.ajkd.2025.06.022_bib47","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1093\/clinchem\/hvab282","article-title":"Clinical impact of the refit CKD-EPI 2021 creatinine-based eGFR equation","volume":"68","author":"Meeusen","year":"2022","journal-title":"Clin Chem"},{"issue":"3","key":"10.1053\/j.ajkd.2025.06.022_bib48","doi-asserted-by":"crossref","first-page":"305","DOI":"10.7326\/M21-2928","article-title":"Prediction of end-stage kidney disease using estimated glomerular filtration rate with and without race : a prospective cohort study","volume":"175","author":"Bundy","year":"2022","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1053\/j.ajkd.2025.06.022_bib49","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1093\/cid\/ciac731","volume":"76","author":"Muiru","year":"2023","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1053\/j.ajkd.2025.06.022_bib50","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1053\/j.ajkd.2024.08.003","article-title":"KDOQI US commentary on the KDIGO 2024 clinical practice guideline for the evaluation and management of CKD","volume":"85","author":"Navaneethan","year":"2025","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.ajkd.2025.06.022_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2020.100662","article-title":"How unmeasured muscle mass affects estimated GFR and diagnostic inaccuracy","volume":"29-30","author":"Nankivell","year":"2020","journal-title":"EClinicalMedicine"},{"issue":"9","key":"10.1053\/j.ajkd.2025.06.022_bib53","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1111\/cts.13354","article-title":"Estimation of glomerular filtration rate for drug dosing in patients with very high or low body mass index","volume":"15","author":"Donker","year":"2022","journal-title":"Clin Transl Sci"},{"issue":"2","key":"10.1053\/j.ajkd.2025.06.022_bib54","doi-asserted-by":"crossref","DOI":"10.1111\/apha.13977","article-title":"Estimating kidney function in patients with cancer: a narrative review","volume":"238","author":"Claudel","year":"2023","journal-title":"Acta Physiol (Oxf)"},{"issue":"2","key":"10.1053\/j.ajkd.2025.06.022_bib55","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1177\/17407745221149118","article-title":"Demographic diversity of US-based participants in GSK-sponsored interventional clinical trials","volume":"20","author":"Reid","year":"2023","journal-title":"Clin Trials"},{"issue":"1","key":"10.1053\/j.ajkd.2025.06.022_bib56","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/s12882-023-03159-5","article-title":"Comparison of CG, CKD-EPI[AS] and CKD-EPI[ASR] equations to estimate glomerular filtration rate and predict mortality in treatment na\u00efve people living with HIV in Zimbabwe","volume":"24","author":"Hunter-Dickson","year":"2023","journal-title":"BMC Nephrol"},{"issue":"5","key":"10.1053\/j.ajkd.2025.06.022_bib57","doi-asserted-by":"crossref","first-page":"674","DOI":"10.4103\/njcp.njcp_485_20","article-title":"Comparability of serum creatinine-based glomerular filtration rate equations in West African adult communities","volume":"24","author":"Akpan","year":"2021","journal-title":"Niger J Clin Pract"},{"issue":"3","key":"10.1053\/j.ajkd.2025.06.022_bib58","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1007\/s11255-011-9928-7","article-title":"Predictive performance of eGFR equations in South Africans of African and Indian ancestry compared with 99mTc-DTPA imaging","volume":"44","author":"Madala","year":"2012","journal-title":"Int Urol Nephrol"},{"issue":"3","key":"10.1053\/j.ajkd.2025.06.022_bib59","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0193384","article-title":"Performance of glomerular filtration rate estimation equations in Congolese healthy adults: the inopportunity of the ethnic correction","volume":"13","author":"Bukabau","year":"2018","journal-title":"PLoS One"},{"issue":"5","key":"10.1053\/j.ajkd.2025.06.022_bib60","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/j.kint.2018.11.045","article-title":"Performance of creatinine- or cystatin C-based equations to estimate glomerular filtration rate in sub-Saharan African populations","volume":"95","author":"Bukabau","year":"2019","journal-title":"Kidney Int"},{"issue":"7","key":"10.1053\/j.ajkd.2025.06.022_bib61","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1093\/ndt\/gfp765","article-title":"Assessment of GFR by four methods in adults in Ashanti, Ghana: the need for an eGFR equation for lean African populations","volume":"25","author":"Eastwood","year":"2010","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"10.1053\/j.ajkd.2025.06.022_bib62","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1159\/000487702","article-title":"Effects of volume overload and current techniques for the assessment of fluid status in patients with renal disease","volume":"46","author":"Ekinci","year":"2018","journal-title":"Blood Purif"},{"issue":"1","key":"10.1053\/j.ajkd.2025.06.022_bib63","doi-asserted-by":"crossref","first-page":"39","DOI":"10.2215\/CJN.03610414","article-title":"Association of fluid overload with cardiovascular morbidity and all-cause mortality in stages 4 and 5 CKD","volume":"10","author":"Tsai","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"issue":"7","key":"10.1053\/j.ajkd.2025.06.022_bib64","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1093\/ndt\/gfz088","article-title":"Clinical trials in end-stage renal disease-priorities and challenges","volume":"34","author":"Kovesdy","year":"2019","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/j.ajkd.2025.06.022_bib65","article-title":"Endogenous markers of kidney function and renal drug clearance processes of filtration, secretion, and reabsorption","volume":"31","author":"Thompson","year":"2022","journal-title":"Curr Opin Toxicol"},{"issue":"2","key":"10.1053\/j.ajkd.2025.06.022_bib66","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1001\/jama.2015.18202","article-title":"Multinational assessment of accuracy of equations for predicting risk of kidney failure: a meta-analysis","volume":"315","author":"Tangri","year":"2016","journal-title":"JAMA"},{"issue":"4","key":"10.1053\/j.ajkd.2025.06.022_bib67","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1056\/NEJMoa2203769","article-title":"Cystatin C-based equation to estimate GFR without the inclusion of race and sex","volume":"388","author":"Pottel","year":"2023","journal-title":"N Engl J Med"}],"container-title":["American Journal of Kidney Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638625010261?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638625010261?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T22:59:12Z","timestamp":1766098752000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272638625010261"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":63,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S0272638625010261"],"URL":"https:\/\/doi.org\/10.1053\/j.ajkd.2025.06.022","relation":{},"ISSN":["0272-6386"],"issn-type":[{"value":"0272-6386","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmaceutical Practice Considerations Regarding Adoption of the Race-Free Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) 2021 Equations","name":"articletitle","label":"Article Title"},{"value":"American Journal of Kidney Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.ajkd.2025.06.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of the National Kidney Foundation, Inc.","name":"copyright","label":"Copyright"}]}}